Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1

M Smith; J De Bono; C Sternberg; S Le Moulec; S Oudard; U De Giorgi; M Krainer; A Bergman; W Hoelzer; Ronald de Wit; M Bogemann; F Saad; G Cruciani; A Thiery-Vuillemin; S Feyerabend; K Miller; N Houede; S Hussain; E (Esther) Lam; J Polikoff; A Stenzl; P Mainwaring; D Ramies; C Hessel; A Weitzman; K Fizazi

doi:10.1200/jco.2015.65.5597

Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1

M Smith
, J De Bono
, C Sternberg
, S Le Moulec
, S Oudard
, U De Giorgi
, M Krainer
, A Bergman
, W Hoelzer
, Ronald de Wit
, M Bogemann
, F Saad
, G Cruciani
, A Thiery-Vuillemin
, S Feyerabend
, K Miller
, N Houede
, S Hussain
, E (Esther) Lam
, J Polikoff

A Stenzl, P Mainwaring, D Ramies, C Hessel, A Weitzman, K Fizazi

Medical Oncology

External organisation

Research output: Contribution to journal › Article › Academic › peer-review

222 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	3005-+
Journal	Journal of Clinical Oncology
Volume	34
Issue number	25
DOIs	https://doi.org/10.1200/jco.2015.65.5597
Publication status	Published - 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research programs

EMC MM-03-86-08

Access to Document

10.1200/jco.2015.65.5597

Cite this

Smith, M., De Bono, J., Sternberg, C., Le Moulec, S., Oudard, S., De Giorgi, U., Krainer, M., Bergman, A., Hoelzer, W., de Wit, R., Bogemann, M., Saad, F., Cruciani, G., Thiery-Vuillemin, A., Feyerabend, S., Miller, K., Houede, N., Hussain, S., Lam, E., ... Fizazi, K. (2016). Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1. Journal of Clinical Oncology, 34(25), 3005-+. https://doi.org/10.1200/jco.2015.65.5597

@article{ea78bdde82af475ab1c67003949e65e9,

title = "Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1",

author = "M Smith and \{De Bono\}, J and C Sternberg and \{Le Moulec\}, S and S Oudard and \{De Giorgi\}, U and M Krainer and A Bergman and W Hoelzer and \{de Wit\}, Ronald and M Bogemann and F Saad and G Cruciani and A Thiery-Vuillemin and S Feyerabend and K Miller and N Houede and S Hussain and Lam, \{E (Esther)\} and J Polikoff and A Stenzl and P Mainwaring and D Ramies and C Hessel and A Weitzman and K Fizazi",

year = "2016",

doi = "10.1200/jco.2015.65.5597",

language = "Undefined/Unknown",

volume = "34",

pages = "3005--+",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams \& Wilkins",

number = "25",

}

Smith, M, De Bono, J, Sternberg, C, Le Moulec, S, Oudard, S, De Giorgi, U, Krainer, M, Bergman, A, Hoelzer, W, de Wit, R, Bogemann, M, Saad, F, Cruciani, G, Thiery-Vuillemin, A, Feyerabend, S, Miller, K, Houede, N, Hussain, S, Lam, E, Polikoff, J, Stenzl, A, Mainwaring, P, Ramies, D, Hessel, C, Weitzman, A & Fizazi, K 2016, 'Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1', Journal of Clinical Oncology, vol. 34, no. 25, pp. 3005-+. https://doi.org/10.1200/jco.2015.65.5597

TY - JOUR

T1 - Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1

AU - Smith, M

AU - De Bono, J

AU - Sternberg, C

AU - Le Moulec, S

AU - Oudard, S

AU - De Giorgi, U

AU - Krainer, M

AU - Bergman, A

AU - Hoelzer, W

AU - de Wit, Ronald

AU - Bogemann, M

AU - Saad, F

AU - Cruciani, G

AU - Thiery-Vuillemin, A

AU - Feyerabend, S

AU - Miller, K

AU - Houede, N

AU - Hussain, S

AU - Lam, E (Esther)

AU - Polikoff, J

AU - Stenzl, A

AU - Mainwaring, P

AU - Ramies, D

AU - Hessel, C

AU - Weitzman, A

AU - Fizazi, K

PY - 2016

Y1 - 2016

U2 - 10.1200/jco.2015.65.5597

DO - 10.1200/jco.2015.65.5597

M3 - Article

SN - 0732-183X

VL - 34

SP - 3005-+

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 25

ER -